As a CRO (Contract Research Organization), Tergus provides topical pharmaceutical R&D, testing and manufacturing services to companies of all sizes with agile and custom solutions. The industry experts in our team apply QbD (Quality by Design) principles to help you with formulation development, analysis, testing and clinical supply manufacturing. We excel in providing you with the best solution and take immense care in risk mitigation strategies.
Read More
Our Competence
Topical Formulation Development
Tergus Pharma is a One-Stop Solution for all of Your Topical Formulation Development Needs.Know More
Manufacturing Facility
Tergus has a state-of-the-art semi-solid manufacturing facility and extensive expertise in the management and...Know More
IVRT (Franz Diffusion)
Tergus Pharma provides significant expertise in In vitro Release Rate Test (IVRT) Method Development & Validation.Know More
Skin Biology
Your API needs to reach its target and maintain efficacy, so skin penetration and permeation studies are a necessity.Know More
Latest News
- Dawn Slann joined Tergus effective June 11, 2018 in the capacity of Senior Director, Quality Assurance.
June 13, 2018) - Tergus Announces Key Leadership Changes
April 25, 2018) - Joint Life Science Caucus Visits the NC Research Campus
(April 06, 2018) - Tergus Pharma announces the Acquisition of EnDev Labs
(March 22, 2018)
Upcoming Events
- Access! 2018 – AAM Annual Meeting
Feb 12 2018 - The 4th Annual Dermatology Innovation Forum
Feb 15 2018 - 2018 AAD Annual Meeting
Feb 16 2018 - CPhI north america
April 24 2018
Ask Experts
Facebook Posts
Unable to display Facebook posts.
Show error
Error: Error validating application. Application has been deleted.
Type: OAuthException
Code: 190
Please refer to our Error Message Reference.
Type: OAuthException
Code: 190
Please refer to our Error Message Reference.